Back
Aspen Technology 10K Form
Buy
57
AZPN
Aspen Technology
Last Price:
199.84
Seasonality Move:
11.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-01-27 | 10Q | AZPN/Aspen Technology Quarterly |
2020-12-22 | 10Q | AZPN/Aspen Technology Quarterly |
2020-12-09 | 10K | AZPN/Aspen Technology Annual |
2020-05-06 | 10Q | AZPN/Aspen Technology Quarterly |
2020-01-29 | 10Q | AZPN/Aspen Technology Quarterly |
2019-10-30 | 10Q | AZPN/Aspen Technology Quarterly |
Receive AZPN News And Ratings
See the #1 stock for the next 7 days that we like better than AZPN
AZPN Financial Statistics
Sales & Book Value
Annual Sales: | $709.38M |
---|---|
Cash Flow: | $47.78M |
Price / Cash Flow: | 60.22 |
Annual Sales: | $202.99 |
Price / Book: | 0.98 |
Profitability
EPS (TTM): | 1.06000 |
---|---|
Net Income (TTM): | $0 |
Gross Margin: | $649.23M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Aspen Technology Earnings Forecast
Key Aspen Technology Financial Ratios
- The Gross Profit Margin over the past 27 years for AZPN is 91.52%.
- The Selling, General & Administrative Expenses for AZPN have been equal to 27.71% of Gross Profit Margin.
- The Research & Development expenses have been 13.28% of Revenue.
- The Interest Expense is 2.27% of Operating Income.
- The Net Earning history of AZPN is 45.08% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 14 years.
Aspen Technology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software - Application |
Sector: | Technology |
Current Symbol: | AZPN |
CUSIP: | 045327 |
Website: | aspentech.com |
Debt
Debt-to-Equity Ratio: | 0.02 |
---|---|
Current Ratio: | 1.73 |
Quick Ratio: | 1.69 |
Price-to-Earnings
Trailing P/E Ratio: | 42.77 |
---|---|
Forward P/E Ratio: | 25.76 |
AZPN Technical Analysis vs Fundamental Analysis
Buy
57
Aspen Technology (AZPN)
is a Buy
Is Aspen Technology a Buy or a Sell?
-
Aspen Technology stock is rated a Buy
The current Aspen Technology [AZPN] share price is $199.75. The Score for AZPN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.